pI: 6.3842 |
Length (AA): 254 |
MW (Da): 29172 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_127535)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G49880 | FAD-linked sulfhydryl oxidase ERV1 |
Babesia bovis | BBOV_II007550 | human hepatopoietin-like protein, putative |
Brugia malayi | Bm1_33230 | Augmenter of liver regeneration |
Candida albicans | CaO19.13905 | similar to S. cerevisiae ERV2 (YPR037C) endoplasmic reticulum flavin-linked sulfhydryl oxidase |
Candida albicans | CaO19.6552 | similar to S. cerevisiae ERV2 (YPR037C) endoplasmic reticulum flavin-linked sulfhydryl oxidase |
Candida albicans | CaO19_6552 | hypothetical protein |
Caenorhabditis elegans | CELE_F56C11.3 | Protein F56C11.3 |
Dictyostelium discoideum | DDB_G0272230 | hypothetical protein |
Drosophila melanogaster | Dmel_CG12534 | Augmenter of liver regeneration |
Echinococcus granulosus | EgrG_001126400 | FAD linked sulfhydryl oxidase ALR |
Echinococcus multilocularis | EmuJ_001126400 | FAD linked sulfhydryl oxidase ALR |
Homo sapiens | ENSG00000127554 | growth factor, augmenter of liver regeneration |
Leishmania braziliensis | LbrM.15.1000 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_151020.1 | ERV/ALR sulfhydryl oxidase domain-containing protein |
Leishmania infantum | LinJ.15.1020 | hypothetical protein, conserved |
Leishmania major | LmjF.15.0960 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.15.0960 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_05818 | hepatopoietin HPO2 |
Mus musculus | ENSMUSG00000040888 | growth factor, erv1 (S. cerevisiae)-like (augmenter of liver regeneration) |
Neospora caninum | NCLIV_041090 | hypothetical protein |
Oryza sativa | 9270137 | Os03g0206300 |
Plasmodium berghei | PBANKA_0203400 | FAD-linked sulfhydryl oxidase ERV1, putative |
Plasmodium falciparum | PF3D7_0110200 | FAD-linked sulfhydryl oxidase ERV1, putative |
Plasmodium knowlesi | PKNH_0203600 | FAD-linked sulfhydryl oxidase ERV1, putative |
Plasmodium vivax | PVX_081280 | FAD-linked sulfhydryl oxidase ERV1, putative |
Plasmodium yoelii | PY00421 | hypothetical protein |
Saccharomyces cerevisiae | YGR029W | Erv1p |
Saccharomyces cerevisiae | YPR037C | Erv2p |
Schistosoma japonicum | Sjp_0051570 | FAD-linked sulfhydryl oxidase ALR, putative |
Schmidtea mediterranea | mk4.000083.18 | FAD-linked sulfhydryl oxidase ALR |
Trypanosoma brucei gambiense | Tbg972.9.3150 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.9.6060 | ERV/ALR sulfhydryl oxidase domain-containing protein |
Trypanosoma congolense | TcIL3000_9_2060 | ERV/ALR sulfhydryl oxidase domain-containing protein |
Trypanosoma congolense | TcIL3000_9_2050 | ERV/ALR sulfhydryl oxidase domain-containing protein |
Trypanosoma cruzi | TcCLB.505843.49 | Present in the outer mitochondrial membrane proteome 4 |
Trypanosoma cruzi | TcCLB.430605.40 | Present in the outer mitochondrial membrane proteome 4 |
Trypanosoma cruzi | TcCLB.509353.20 | ERV/ALR sulfhydryl oxidase domain-containing protein |
Toxoplasma gondii | TGME49_210787 | Erv1 / Alr family protein |
Toxoplasma gondii | TGME49_288620 | Erv1 / Alr family protein |
Theileria parva | TP02_0206 | hypothetical protein, conserved |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.160.4440 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.160.4440 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.160.4440 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.160.4440 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
YGR029W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0203400 | Plasmodium berghei | Essential | plasmo |
TGME49_288620 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_210787 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_288620 | Toxoplasma gondii | Probably essential | sidik |
TGME49_210787 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | growth factor, augmenter of liver regeneration | Compounds | References |